Autolus Therapeutics is listing its ADR shares on the Nasdaq exchange, and Jefferies Financial Group has issued research reports on the company.
2 reports, 1 independent
Updated Aug 8
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Autolus Therapeutics is listing its ADR shares on the Nasdaq exchange, and Jefferies Financial Group has issued research reports on the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Autolus Therapeutics
company in London, United Kingdom
Nothing else this week.
-
Jefferies Financial Group
American financial services company
-
Nasdaq
American fully electronic stock exchange
Related events
- Generate Biomedicines Inc listed its shares on the Nasdaq exchange and received research notes and ratings from Cantor Fitzgerald.
- Tenax Therapeutics listed on Nasdaq and received research reports from Cantor Fitzgerald, attracting investment from ADAR1 Capital Management.
- Telix Pharmaceuticals Limited announced that it is utilizing the Nasdaq exchange for its ADR listing.
- ADMA Biologics, Inc. filed a lawsuit and was listed on the Nasdaq stock exchange.
- Compass Pathways ADR trading on the Nasdaq stock exchange.